Skip to Main Content

++
Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print
AbAntibody
AbnAbnormal
AFBAcid-fast bacillus
AgAntigen
AIDSAcquired immunodeficiency syndrome
ALTAlanine aminotransferase
ANAAntinuclear antibody
ASTAspartate aminotransferase
CBCComplete blood cell count
CFComplement fixation
CHFCongestive heart failure
CIECounterimmunoelectrophoresis
CKCreatine kinase
CNSCentral nervous system
CSFCerebrospinal fluid
CXRChest x-ray
CYPCytochrome P450
DiffDifferential cell count
EDTAEthylenediaminetetraacetic acid (edetate)
ELISAEnzyme-linked immunosorbent assay
GIGastrointestinal
GNRGram-negative rod
GNCBGram-negative coccobacillus
GPCGram-positive coccus
GVCBGram-variable coccobacillus
HLAHuman leukocyte antigen
IgImmunoglobulin
IMIntramuscular(ly)
INRInternational Normalized Ratio
IVIntravenous(ly)
MinMinute
MNMononuclear cell
MRIMagnetic resonance imaging
NNormal
NegNegative
NPONothing by mouth (nil per os)
PCRPolymerase chain reaction
PMNPolymorphonuclear neutrophil (leukocyte)
POOrally (per os)
PosPositive
PTHParathyroid hormone
RBCRed blood cell
RPRRapid plasma reagin (syphilis test)
SIADHSyndrome of inappropriate antidiuretic hormone (secretion)
SLESystemic lupus erythematosus
T3Triiodothyronine
T4Tetraiodothyronine (thyroxine)
TSHThyroid-stimulating hormone
VVariable
VDRLVenereal Disease Research Laboratory (syphilis test)
WBCWhite blood cell
WkWeek
YrYear
Increased
Decreased
No change
++

The basic assumptions underlying therapeutic drug monitoring (Table 4–1) are that drug metabolism varies from patient to patient and that the plasma level of a drug is more closely related to the drug's therapeutic effect or toxicity than is the dosage.

++
Table Graphic Jump Location
Table 4–1. Therapeutic Drug Monitoring.1

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.